Sanofi Files Patent-Infringement Suit Against Mylan in the U.S.
25 October 2017 - 7:59PM
Dow Jones News
By Marc Bisbal Arias
Sanofi SA (SAN.FR) said late Tuesday that it has brought a
patent-infringement suit against Mylan NV (MYL) in a U.S. court
over the French company's disposable insulin pen and vial-drug
products for diabetes.
The pharmaceutical said that the suit it filed in the U.S.
District Court for the District of New Jersey alleges that Mylan
infringed 18 of its patents.
Sanofi said it filed the motion after receiving notification
from the American company in mid-September stating that it had
submitted a new drug application to the U.S. Food and Drug
Administration for an insulin glargine pre-filled pen and vial-drug
products.
The company said that the new drug application challenges its
patents for Lantus and Lantus SoloSTAR products.
Write to Marc Bisbal Arias at marc.bisbalarias@dowjones.com
(END) Dow Jones Newswires
October 25, 2017 04:44 ET (08:44 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024